Pfizer buckles under pressure from Trump, delays drug price increases
By Damian Paletta
July 10 at 7:43 PM
Pfizer chief executive Ian Read said late Tuesday that his company would delay increasing the prices of dozens of drug products after President Trump publicly berated the firm one day earlier.
The company, in a statement, said the price increases would effectively be postponed at least until the beginning of 2019 “to give the president an opportunity to work on his blueprint to strengthen the healthcare system and provide more access to patients.”
The announcement marked a successful use of the bully pulpit for Trump and a relatively rapid concession by one of the country’s largest companies. Pfizer moved on July 1 to raise the prices on 41 drug products. Trump, on Monday, tweeted that the company should be “ashamed” and vowed an unspecified response.
Link to tweet
Trump’s threat does not appear to have substantially affected Pfizer’s stock price, but the firm could have decided that it was unwise to risk become a punching bag for Trump. The president has previously accused the pharmaceutical industry of “getting away with murder” and floated the idea of pushing down drug prices through a government-arranged bidding process. He backed down from that threat in May, but he retains the option.
Trump on Tuesday praised Read for his decision to delay the price increases.
Link to tweet
more
https://www.washingtonpost.com/news/business/wp/2018/07/10/pfizer-buckles-under-pressure-from-trump-delays-drug-price-increases/
= new reply since forum marked as read
and Trump, you fuckhead, regarding your phrase, "so American patients don’t pay more", we already pay more than any other country! 
